Quadrant Private Wealth Management’s Century Therapeutics IPSC Stock Holding History

Quadrant Private Wealth Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.2K	Buy	20,022 +4,736	+31%	+$9.96K	0.01%	278
2025 Q4	$15.2K	Hold	15,286	–	–	﹤0.01%	273
2025 Q3	$7.61K	Hold	15,286	–	–	﹤0.01%	252
2025 Q2	$8.54K	Buy	+15,286	New	+$8.2K	﹤0.01%	250

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Quadrant Private Wealth Management's IPSC Position: Q1 2026 in Review

Quadrant Private Wealth Management increased its Century Therapeutics (IPSC) stake by 31% in Q1 2026, buying an estimated $9.96K and bringing the position to 20,022 shares worth $45.2K. The position accounts for 0.01% of the portfolio, ranked #278.

Quadrant Private Wealth Management first reported a position in IPSC in Q2 2025 and has held it in 4 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Quadrant Private Wealth Management held 20,022 shares of Century Therapeutics worth $45.2K as of Q1 2026.
Quadrant Private Wealth Management bought 4,736 Century Therapeutics shares in Q1 2026, an estimated $9.96K.
Century Therapeutics made up 0.01% of Quadrant Private Wealth Management's portfolio in Q1 2026, its #278 holding.
Quadrant Private Wealth Management first reported a position in Century Therapeutics in Q2 2025 and has held it in 4 quarters since.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.